|
|
|
Corporate Profile: Kereos
| Summary: |
Kereos is focused on development ligand-targeted emulsion candidates targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease.
|
| Address (HQ): |
4041 Forest Park Avenue
Saint Louis, MO 63108 |
| Phone #'s (HQ): |
| Main |
(314) 633-1879 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(314) 633-1878 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
